...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZHCLF
1
Jan 03, 2024 11:19AM
1
Jan 03, 2024 05:13PM
2
Jan 03, 2024 06:48PM
1
Jan 03, 2024 09:36PM
1
Jan 03, 2024 10:53PM
2
Jan 03, 2024 10:56PM
2
Jan 04, 2024 07:35AM
1
Jan 30, 2024 02:24PM
4
Jan 30, 2024 04:37PM
1
Jan 31, 2024 08:28AM
3
Feb 01, 2024 08:20AM
3
Feb 01, 2024 10:24AM
6
Feb 01, 2024 10:55AM
5
Feb 02, 2024 07:27AM

Narmac, still crickets from your question to IR or info@Zenith, last week?  I am going to go on a limb and say after 11 years of Zen3694 Trials and the fact that at the AGM  in October DM stated the option of going down a cheaper route of a Royalty deal with a BP that a deal will come  between now and  December of 2024.  RVX is dead in the water without a  Zenith deal and yet the  RVX bills keep getting paid so I think a deal is pending ,  I have been wrong with expectations from Zenith  many many times on   but even the sun shines on a dogs ass once in a while  ......

3
Feb 08, 2024 06:43AM
4
Feb 08, 2024 06:53AM
6
Feb 08, 2024 10:46AM
8
Feb 11, 2024 07:57AM
Share
New Message
Please login to post a reply